Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triethyl Citrate SCHEMBL28306859 | 0.89 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL73474 | 0.89 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL8107357 | 0.89 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10TSHRMAPT | |
| SCHEMBL27677366 | 0.87 | ALDH1A1 (0.31) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL14164382 | 0.87 | ALDH1A1 (0.46) | ALDH1A1HSD17B10TSHRCYP2C19 | |
| SCHEMBL28784375 | 0.87 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| Ammonia Solution, Strong SCHEMBL28679472 | 0.87 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL2118956 | 0.87 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10GAAMGAM | |
| SCHEMBL9728575 | 0.87 | ALDH1A1 (0.46) | ALDH1A1HSD17B10TSHRCYP2C19 | |
| SCHEMBL28189565 | 0.87 | ALDH1A1 (0.46) | ALDH1A1HSD17B10TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113425696-B | Effervescent preparation of compound oral rehydration salt and preparation process and application thereof | 上海耀大生物科技有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-111298667-B | Polymer-based blended film, and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2021-12-07 | — | — | CN | claimed |
| CN-113425696-A | Effervescent preparation of compound oral rehydration salt and preparation process and application thereof | 上海耀大生物科技有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-107955350-B | Full-biodegradable drug-resistant mulching film composition and preparation method thereof | 山东天野生物降解新材料科技有限公司 | 2020-07-21 | — | — | CN | claimed |
| CN-111298667-A | Polymer-based blended film, and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2020-06-19 | — | — | CN | claimed |
| CN-107936507-B | Mulching film for inhibiting weed growth and preparation method thereof | 山东天野生物降解新材料科技有限公司 | 2020-01-14 | — | — | CN | claimed |
| EP-2623096-B1 | Pharmaceutical composition with slow release of trimetazidine | SERVIER LAB (FR) | 2019-04-03 | — | — | EP | claimed |
| US-10117838-B2 | Pharmaceutical composition for the prolonged release of trimetazidine | LES LABORATOIRES SERVIER (FR) | 2018-11-06 | — | — | US | claimed |
| WO-2018033621-A1 | COMPOSITION FOR PREPARING AN ELECTROCHROMIC LAYER | BASF SE (DE) | 2018-02-22 | — | — | WO | claimed |
| CN-103456983-B | Solid thin film electrolyte material and preparation method thereof | 桂林电子科技大学 | 2016-10-19 | — | — | CN | claimed |
| US-20130202710-A1 | PHARMACEUTICAL COMPOSITION FOR THE PROLONGED RELEASE OF TRIMETAZIDINE | LES LABORATOIRES SERVIER (FR) | 2013-08-08 | — | — | US | claimed |
| US-6983801-B2 | Well treatment fluid compositions and methods for their use | BJ SERVICES COMPANY (US) | 2006-01-10 | — | — | US | claimed |
| US-20050016733-A1 | Well treatment fluid compositions and methods for their use | COMBINED SYSTEMS, INC. | 2005-01-27 | — | — | US | claimed |
| US-6793018-B2 | Solvent (such as water), a polymer soluble or hydratable in the solvent, a crosslinking agent such as a borate, an inorganic breaking agent, and an ester such as acetyl triethyl citrate; initial high viscosity, then low viscosity | BJ SERVICES COMPANY | 2004-09-21 | — | — | US | claimed |
| US-20020125012-A1 | Well treatment fluid compositions and methods for their use | BJ SERVICES COMPANY | 2002-09-12 | — | — | US | claimed |
| WO-2002055843-A1 | WELL TREATMENT FLUID COMPOSITIONS AND METHODS FOR THEIR USE | BJ SERVICES COMPANY (US) | 2002-07-18 | — | — | WO | claimed |
| EP-4419510-B1 | NOVEL TRIMETAZIDINE SALTS | SERVIER LAB (FR) | 2025-10-08 | — | — | EP | disclosed |
| US-20250250245-A1 | TRIMETAZIDINE SALTS | LES LABORATOIRES SERVIER (FR) | 2025-08-07 | — | — | US | disclosed |
| WO-2012028698-A1 | MESALAZINE TABLET HAVING IMPROVED DISSOLUTION | DISPHAR INTERNATIONAL B.V. (NL) | 2012-03-08 | — | — | WO | disclosed |
| US-5134138-A | ANTIBIOTICS | SHIONOGI & CO., LTD. (JP) | 1992-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250245-A1 | TRIMETAZIDINE SALTS | TRIM4, NNMT, NOX5 | ALDH1A1 207/4885LMNA 3141/4885HSD17B10 376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.